Support for center for tobacco products (CTP) tobacco economic data review and analysis (TEDRA)
Active Awarded Last action
- Contract number
- 75F40126F19004
- Awardee
-
Industrial Economics Inc. UEI F1BNQ68LSJ61
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $892,513
Award facts
- Contract value 43% obligated
-
- $892,513.20 Current, with exercised options
- $2,056,792.60 Potential, with all options
- Completion date 22% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Cambridge, MA 02140, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $450,787 | |
| Original award | $441,726 |
About this award
The Food and Drug Administration issued a BPA call to Industrial Economics Inc. on October 30, 2025, for support of the Center for Tobacco Products Tobacco Economic Data Review and Analysis (TEDRA) program, with a ceiling value of $2,056,792.60 and an ultimate completion date of May 2, 2030. The call is priced on a time-and-materials basis and is performed in Cambridge, Massachusetts.
IEC holds a $9.8 million FDA tobacco policy and regulatory analysis BPA (awarded May 2024, through May 2027) that serves as the parent vehicle for this call. The call delivers economic data review and analysis services supporting FDA's tobacco regulatory and policy functions under Executive Order 14398. The parent BPA encompasses tobacco policy analysis, regulatory impact modeling, and economic assessments across FDA's tobacco regulatory portfolio.
Subcontractors supporting this effort include Concordian Corporation, a woman-owned small business providing project management and software development; Arisglobal, LLC, providing subject matter expert and product support services; Momento USA LLC and Vets Synergetic Group LLC providing system analysis and software engineering expertise for the FDA's Adverse Event Monitoring System platform; and Agisol LLC, an 8(a)-certified, economically disadvantaged woman-owned small business, providing software engineering support. IEC self-performs the majority of analytical and economic modeling work with a multi-vendor technical and IT services team.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Concordian Corporation | $329,000 | |
| Arisglobal, LLC | $546,392 | |
| Momento USA LLC | $202,413 | |
| Vets Synergetic Group LLC | $375,370 | |
| Subcontractor not on record | $126,886 | |
| Agisol LLC | $109,755 |
Quick answers
Who was awarded contract 75F40126F19004?
75F40126F19004 was awarded to Industrial Economics Inc. by Food and Drug Administration (Department of Health and Human Services) on October 30, 2025.
How much is contract 75F40126F19004 worth?
The government has obligated $892,513 on 75F40126F19004. Its potential value, with all options, is $2,056,793.
Is contract 75F40126F19004 an order under another contract?
Yes. 75F40126F19004 is a BPA call under 47QRAA20D0044-75F40124A00004, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40126F19004 competed?
The extent of competition for 75F40126F19004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award